GLP-1 medications have emerged as a physician-supervised option for individuals managing obesity or weight-related conditions ...

Three years ago, Mercedes Lamphere was selling drinks infused with THC from the back of her truck. Today, those intoxicating, yet alcohol-free beverages can be found in 850 locations across 10 states.

The Motley Fool. DATE Friday, June 20, 2025 at 10 a.m. ET Read More: Earn up to $845 cash back this year just by changing how ...

The ongoing open-label APeX-P study is evaluating the pharmacokinetic, safety, and effectiveness of berotralstat in children aged 2 to 11 years with HAE. Patients were enrolled into four weight-based ...

The initial proceeds to Immunic from the offering were approximately $65 million, before deducting underwriting discounts and commissions and offering expenses. The Company may receive up to an ...

Important: Notifying Health Canada of a new cannabis product does not constitute approval for sale by Health Canada, nor does it mean that the product complies with legislative requirements. It is ...

This guide does not cover broader requirements under the Act and Regulations such as those related to licensing, physical security, packaging and labelling ... 96(1), CR]. Maximum net weight: the net ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

Talazoparib-Enzalutamide for mCRPC In 2023, the FDA approved talazoparib in combination ... TALAPRO-2 was insufficient to support this broad label expansion. In particular, FDA reviewers were ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up on supplies and fretting about the future of their treatment.

The weight-loss industry is a huge one in the ... the same active ingredients but were not approved by the U.S. Food and Drug Administration." But, a few months ago, the FDA announced that ...